Evidence map›Paper›PMID 39572788›Full record

ArticleNature microbiology2024

The Parkinson's disease drug entacapone disrupts gut microbiome homoeostasis via iron sequestration.

Fátima C Pereira, Xiaowei Ge, Jannie M Kristensen, Rasmus H Kirkegaard, Klara Maritsch, Dávid Szamosvári, Stefanie Imminger, David Seki, Juwairiyah B Shazzad, Yifan Zhu and 8 more

Abstract read
In one paragraph

Article in Nature microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Gut microbes · 2025
    Article
  6. Article
  7. Gut Microbiome as a Source of Probiotic Drugs for Parkinson's Disease.International journal of molecular sciences · 2025
    Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors.

Fátima C Pereira *Centre for Microbiology and Environmental Systems Science, Department of Microbiology and Ecosystem Science, University of Vienna, Vienna, Austria. f.c.pereira@soton.ac.uk.ORCID http://orcid.org/0000-0002-1288-6481
Xiaowei Ge *Department of Electrical and Computer Engineering, Boston University, Boston, MA, USA.ORCID http://orcid.org/0000-0001-8938-9304
Jannie M KristensenCentre for Microbiology and Environmental Systems Science, Department of Microbiology and Ecosystem Science, University of Vienna, Vienna, Austria.ORCID http://orcid.org/0000-0001-7471-7934
Rasmus H KirkegaardCentre for Microbiology and Environmental Systems Science, Department of Microbiology and Ecosystem Science, University of Vienna, Vienna, Austria.ORCID http://orcid.org/0000-0003-3349-3617
Klara MaritschCentre for Microbiology and Environmental Systems Science, Department of Microbiology and Ecosystem Science, University of Vienna, Vienna, Austria.
Dávid SzamosváriDepartment of Biological Chemistry, Faculty of Chemistry, University of Vienna, Vienna, Austria.
Stefanie ImmingerCentre for Microbiology and Environmental Systems Science, Department of Microbiology and Ecosystem Science, University of Vienna, Vienna, Austria.ORCID http://orcid.org/0000-0002-4267-8085
David SekiCentre for Microbiology and Environmental Systems Science, Department of Microbiology and Ecosystem Science, University of Vienna, Vienna, Austria.
Juwairiyah B ShazzadSchool of Biological Sciences, University of Southampton, Southampton, UK.ORCID http://orcid.org/0009-0003-3263-370X
Yifan ZhuDepartment of Chemistry, Boston University, Boston, MA, USA.
Marie DecorteCentre for Microbiology and Environmental Systems Science, Department of Microbiology and Ecosystem Science, University of Vienna, Vienna, Austria.
Bela HausmannDepartment of Biological Chemistry, Faculty of Chemistry, University of Vienna, Vienna, Austria.ORCID http://orcid.org/0000-0002-0846-1202
David BerryCentre for Microbiology and Environmental Systems Science, Department of Microbiology and Ecosystem Science, University of Vienna, Vienna, Austria.ORCID http://orcid.org/0000-0002-8997-608X
Kenneth WasmundCentre for Microbiology and Environmental Systems Science, Department of Microbiology and Ecosystem Science, University of Vienna, Vienna, Austria.
Arno SchintlmeisterCentre for Microbiology and Environmental Systems Science, Department of Microbiology and Ecosystem Science, University of Vienna, Vienna, Austria.ORCID http://orcid.org/0000-0002-1146-0032
Thomas BöttcherCentre for Microbiology and Environmental Systems Science, Department of Microbiology and Ecosystem Science, University of Vienna, Vienna, Austria.ORCID http://orcid.org/0000-0003-0235-4825
Ji-Xin ChengDepartment of Electrical and Computer Engineering, Boston University, Boston, MA, USA. jxcheng@bu.edu.ORCID http://orcid.org/0000-0002-5607-6683
Michael WagnerCentre for Microbiology and Environmental Systems Science, Department of Microbiology and Ecosystem Science, University of Vienna, Vienna, Austria. michael.wagner@univie.ac.at.ORCID http://orcid.org/0000-0002-9778-7684

Funding

Vibrational Spectroscopic Imaging to Unveil Hidden Signatures in Living SystemsR35GM136223 · NIGMS · BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) · PI CHENG, JI-XIN · 2020 to 2025
$5.7M
Rapid AST through Metabolic Imaging at Single Cell LevelR01AI141439 · NIAID · BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) · PI Ji-Xin Cheng · 2019 to 2026
$4.7M
High-content High-speed Chemical Imaging of Metabolic Reprogramming by Integration of Advanced Instrumentation and Data ScienceR01EB032391 · NIBIB · BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) · PI CHENG, JI-XIN · 2022 to 2025
$2.0M
Advanced laser scanning confocal microscope for multiple usersS10OD024993 · OD · BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) · PI MERTZ, JEROME · 2018 to 2018
$448k
Austrian Science Fund (Fonds zur Förderung der Wissenschaftlichen Forschung) 10.55776 COE 7Austrian Science Fund (Fonds zur Förderung der Wissenschaftlichen Forschung) 10.55776; COE 7Austrian Science Fund (Fonds zur Förderung der Wissenschaftlichen Forschung) Z383-BAustrian Science Fund (Fonds zur Förderung der Wissenschaftlichen Forschung) ZK-57NIAID NIH HHS R01 AI141439NIBIB NIH HHS R01 EB032391NIGMS NIH HHS R35 GM136223NIH HHS S10 OD024993U.S. Department of Health & Human Services | National Institutes of Health (NIH) R01AI141439U.S. Department of Health & Human Services | National Institutes of Health (NIH) R01EB032391U.S. Department of Health & Human Services | National Institutes of Health (NIH) R35GM136223
6 · The paper itself

Abstract

Many human-targeted drugs alter the gut microbiome, leading to implications for host health. However, the mechanisms underlying these effects are not well known. Here we combined quantitative microbiome profiling, long-read metagenomics, stable isotope probing and single-cell chemical imaging to investigate the impact of two widely prescribed drugs on the gut microbiome. Physiologically relevant concentrations of entacapone, a treatment for Parkinson's disease, or loxapine succinate, used to treat schizophrenia, were incubated ex vivo with human faecal samples. Both drugs significantly impact microbial activity, more so than microbial abundance. Mechanistically, entacapone can complex and deplete available iron resulting in gut microbiome composition and function changes. Microbial growth can be rescued by replenishing levels of microbiota-accessible iron. Further, entacapone-induced iron starvation selected for iron-scavenging gut microbiome members encoding antimicrobial resistance and virulence genes. These findings reveal the impact of two under-investigated drugs on whole microbiomes and identify metal sequestration as a mechanism of drug-induced microbiome disturbance.

Indexed as

CatecholsFecesGastrointestinal MicrobiomeIronNitrilesParkinson DiseaseAntiparkinson AgentsBacteriaHomeostasisHumansMetagenomicsAntiparkinson AgentsCatecholsentacaponeIronNitriles

Identifiers

PMID39572788
PMCPMC11602724

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.